Authors:
MORALES J
DURAN C
ARTIGAS G
MUNOZ G
FIERRO A
VUKUSICH A
MANALICH J
BRAHM J
Citation: J. Morales et al., IMPACT OF PROPHYLACTIC MEASURES ON PREVALENCE OF ANTI HCV AND VIRAL GENOTYPES IN A DIALYSIS UNIT, Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2805-2807
Authors:
GOEREE R
MANALICH J
GROOTENDORST P
BEECROFT ML
CHURCHILL DN
Citation: R. Goeree et al., COST-ANALYSIS OF DIALYSIS TREATMENTS FOR END-STAGE RENAL-DISEASE (ESRD), Clinical and investigative medicine, 18(6), 1995, pp. 455-464
Citation: L. Elgueta et al., QUALITY-OF-LIFE ASSESSMENT IN PATIENTS OL DER THAN 60 YEARS IN CHRONIC-HEMODIALYSIS PROGRAMS, Revista Medica de Chile, 122(6), 1994, pp. 679-685